Categories
OpenSource Resources

UMLS APIs for clinical vocabularies

Originally published by Bell Eapen at nuchange.ca on August 20, 2019. If you have some feedback, reach out to the author on Twitter,  LinkedIn or  Github.

UMLS, or Unified Medical Language System, is a set of files and software that brings together many health and biomedical vocabularies and standards to enable interoperability between computer systems.

Natural Language Processing (NLP) on the vast amount of data captured by electronic medical records (EMR) is gaining popularity. The recent advances in machine learning (ML) algorithms and the democratization of high-performance computing (HPC) have reduced the technical challenges in NLP. However, the real challenge is not the technology or the infrastructure, but the lack of interoperability — in this case, the inconsistent use of terminology systems.


natural language processing
UMLS for NLP

NLP tasks start with recognizing medical terms in the corpus of text and converting it into a standard terminology space such as SNOMED and ICD. This requires a terminology mapping service that can do this mapping in an easy and consistent manner. The Unified Medical Language System (UMLS) terminology server is the most popular for integrating and distributing key terminology, classification and coding standards. The consistent use of  UMLS resources leads to effective and interoperable biomedical information systems and services, including EMRs.


To make things easier, UMLS provides both REST-based and SOAP-based services that can be integrated into software applications. A high-level library that encapsulated these services, making the REST calls easy to the user is required for the efficient use of these resources.  Umlsjs is one such high-level library for the UMLS REST web services for javascript. It is free, open-source and available on NPM, making it easy to integrate into any javascript (for browsers) or any nodejs applications.


The umlsjs package is available on GitHub and the NPM. It is still work in progress and any coding/documentation contributions are welcome. Please read the CONTRIBUTING.md file on the repository for instructions. If you use it and find any issues, please report it on GitHub.


Categories
Healthcare Analytics Research

Elasticsearch for analyzing CORD-19 dataset

COVID-19 Open Research Dataset (CORD-19) is a dataset of approximately 47,000 scholarly articles, about COVID-19, SARS-CoV-2, and related coronaviruses made free to the research community by a coalition of research groups. The articles are provided as JSON files for the global research community to apply natural language processing.

Siouxsie Wiles and Toby Morris / CC BY-SA (https://creativecommons.org/licenses/by-sa/4.0)

Elasticsearch (ES) is a Lucene based text search engine using schema-free JSON documents. Elasticsearch is fast and has clients libraries available for most programming languages including python. Loading the COVID-19 data on to an ES instance will be helpful for easy search and analysis, all within the comfort of the jupyter notebook. The availability of the Apache spark (spark) connector makes the exchange of data between ES and spark easy. I have listed below, the simple steps to load the files to an ES instance.

First, download and install ES and the ES-spark connector from here, and start ES. Next, Download and install Apache spark from here: https://spark.apache.org/ CORD-19 dataset is available here.

STEP 1: Create a spark session: (add the path to the connector jar)

STEP 2: Load the JSON files:

+——–+——————–+——————–+——————–+——–+——————–+——————–+
|abstract| back_matter| bib_entries| body_text|metadata| paper_id| ref_entries|
+——–+——————–+——————–+——————–+——–+——————–+——————–+
| []|[[[[456,, 453, 8 …|[[[[R, Zhang, [],…|[[[], [], , i c ,…| [[], ]|28b10724357672324…|[[, Fumagalli M, …|
+——–+——————–+——————–+——————–+——–+——————–+——————–+
only showing top 1 row

STEP 3: Select the required fields:

+——————–+——————–+——————–+——————–+——————–+
| paper_id| metadata.title| metadata.authors| abstract.text| body_text.text|
+——————–+——————–+——————–+——————–+——————–+
|28b10724357672324…| | []| []|[i c , a n t i f …|
|1aa3e788fc6b03c14…|Dark Proteome of …|[[[Himachal Prade…|[Recently emerged…|[World health org…|
|558d318e1655da9f5…|Connectivity anal…|[[[University of …|[We utilized a ce…|[Schizophrenia is…|
+——————–+——————–+——————–+——————–+——————–+
only showing top 3 rows

STEP 4: Create an index and write the spark df into ES:

STEP 5: Do the search!

That’s it! You can now use it for search and do analytics on the returned records. Next, I will show you how to use QRMine on CORD-19!

Categories
Research Resources

McMaster develops tool for COVID-19 battle

This article was first published on Brighter World. Read the original article.

McMaster University researchers have developed a tool to share with the international health sciences community which can help determine how the coronavirus that causes COVID-19 is spreading and whether it is evolving.

Simply put, the tool is a set of molecular ‘fishing hooks’ to isolate the virus, SARS-CoV-2, from biological samples. This allows laboratory researchers to gain insight into the properties of the isolated virus COVID-19 by then using a technology called next-generation sequencing.

The details were published on Preprints.org.

“You wouldn’t use this technology to diagnose the patient, but you could use it to track how the virus evolves over time, how it transmits between people, how well it survives outside the body, and to find answers to other questions,” said principal investigator Andrew McArthur, associate professor of biochemistry and biomedical sciences, and a member of the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster.

“Our tool, partnered with next-generation sequencing, can help scientists understand, for example, if the virus has evolved between patient A and patient B.”

McArthur points out that the standard technique to isolate the virus involves culturing it in cells in contained labs by trained specialists. The McMaster tool gives a faster, safer, easier and less-expensive alternative, he said.

“Not every municipality or country will have specialized labs and researchers, not to mention that culturing a virus is dangerous,” he said.

“This tool removes some of these barriers and allows for more widespread testing and analyses.”

First author Jalees Nasir, a PhD candidate in biochemistry and biomedical sciences at McMaster, has been working with McMaster and Sunnybrook Health Sciences Centre researchers to develop a bait capture tool that can specifically isolate respiratory viruses. When news recently broke of COVID-19, Nasir knew he could develop a “sequence recipe” to help researchers to isolate the novel virus more easily.

“When you have samples from a patient, for example, it can consist of a combination of virus, bacteria and human material, but you’re really only interested in the virus,” Nasir said. “It’s almost like a fishing expedition. We are designing baits that we can throw into the sample as hooks and pull out the virus from that mixture.”

The decision was made to release the sequences publicly without the normal practice of peer-review or clinical evaluation to ensure this tool was available to all quickly, recognizing the urgency of the situation, said McArthur.

The research team plans to collaborate with Sunnybrook for further testing but also hopes other scientists can quickly perform their own validation.

McArthur added that a postdoctoral fellow in his lab, David Speicher, is currently communicating details of the technology to the international clinical epidemiology community.

“Since we’re dealing with an outbreak, there was no value in us doing a traditional academic study and the experiments,” said McArthur. “We designed this tool and are releasing it for use by others.

“In part, we’re relying on our track record of knowing what we are doing, but we’re also relying on people who have the virus samples in hand being able to do the validation experiment so that it’s reliable.”

The research was funded by the Comprehensive Antibiotic Resistance Database at McMaster.

This article was first published on Brighter World. Read the original article.

Categories
Research

Researchers discover new toxin that impedes bacterial growth

This article was first published on Brighter World. Read the original article.

An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.

The discovery of this growth-inhibiting toxin, which bacteria inject into rival bacteria to gain a competitive advantage, was published today in the journal Nature.

The discovery is the result of teamwork by co-senior authors John Whitney, assistant professor of the Department of Biochemistry and Biomedical Sciences at McMaster University, and Mike Laub, professor of biology at the Massachusetts Institute of Technology (MIT).

Whitney and his PhD student Shehryar Ahmad at McMaster’s Michael G. DeGroote Institute for Infectious Disease Research were studying how bacteria secrete antibacterial molecules when they came across a new toxin. This toxin was an antibacterial enzyme, one the researchers had never seen before.

After determining the molecular structure of this toxin, Whitney and Ahmad realized that it resembles enzymes that synthesize a well-known bacterial signalling molecule called (p)ppGpp. This molecule normally helps bacteria survive under stressful conditions, such as exposure to antibiotics.

“The 3D structure of this toxin was at first puzzling because no known toxins look like enzymes that make (p)ppGpp, and (p)ppGpp itself is not a toxin,” said Ahmad.

Suspecting the toxin might kill bacteria by overproducing harmful quantities of (p)ppGpp, the McMaster team shared their findings with Laub, an investigator of the U.S. Howard Hughes Medical Institute.

Boyuan Wang, a postdoctoral researcher in the Laub lab who specializes in (p)ppGpp signaling, examined the activity of the newly discovered enzyme. He soon realized that rather than making (p)ppGpp, this enzyme instead produced a poorly understood but related molecule called (p)ppApp. Somehow, the production of (p)ppApp was harmful to bacteria.

The researchers determined that the rapid production of (p)ppApp by this enzyme toxin depletes cells of a molecule called ATP. ATP is often referred to as the ‘energy currency of the cell’ so when the supply of ATP is exhausted, essential cellular processes are compromised and the bacteria die.

“I find it absolutely fascinating that evolution has essentially “repurposed” an enzyme that normally helps bacteria survive antibiotic treatment and, instead, has deployed it for use as an antibacterial weapon,” said Whitney.

The research conducted at McMaster University was funded by the Canadian Institutes for Health Research and is affiliated with the CIHR Institute for Infection and Immunity (CIHR-III) hosted at McMaster University with additional funding from the David Braley Centre for Antibiotic Discovery. The research at MIT was supported by the Howard Hughes Medical Institute and the U.S. National Institutes of Health.

“This is an important discovery with potential implications for developing alternatives to antibiotics, a global priority in the fight against antimicrobial resistance. It is heartening to see that young Canadian researchers like Dr. Whitney are thriving and emerging as leaders in this area,” said Charu Kaushic, scientific director of the CIHR-III and a professor of pathology and molecular medicine at McMaster.

Categories
Uncategorized

OSCAR in a BOX – Virtualized and fault-tolerant OSCAR EMR

Originally published by Bell Eapen at nuchange.ca on August 20, 2019. If you have some feedback, reach out to the author on Twitter,  LinkedIn or  Github.

TL;DROSCAR in a BOX is a fault-tolerant OSCAR instance that you can use out of the box and is virtually maintenance-free!

Image credit DarkoStojanovic @ Pixabay

OSCAR EMR is an open-source Electronic Medical Record (EMR) for the Canadian family physicians. The official OSCAR repository is available here: https://bitbucket.org/oscaremr/

OSCAR is a spring java application deployed in a tomcat container with MySQL database backend. OSCAR project being relatively old, with few users outside Canada, has struggled to keep pace with the developments in the electronic health records domain. However, OSCAR is still useful and popular among family physicians and some public health organizations as it is free and well supported.

Oscar is known for its support for the billing workflow, data collection forms (eForms) and comprehensive patient charts (eCharts). Some of the limitations of OSCAR include lack of scalability beyond a handful of users and limited support for data analytics. Oscar by design is hard to be virtualized as a docker container. Availability of a docker container is crucial for sustainable and fault-tolerant deployment on the cloud and distributed systems such as Kubernetes.

Docker is the world’s leading software container platform, used mostly for DevOps. Docker is also useful for developers to set up a development environment in a few easy steps. I was one of the first few who worked on virtualizing OSCAR. Thanks for all those who forked (and hopefully used) this repository.

I have continued my work on OSCAR docker container and has been successful in creating a (reasonably stable) container. It is now available on docker hub. I am now working on a fault-tolerant deployment of OSCAR in customized hardware. I (and some of my friends who know about and encouraged this project) call it OSCAR in a BOX! It has multiple instances of OSCAR with each instance capable of self-healing when a JAVA process hangs (fairly common for OSCAR). The database is replicated, and both the database and documents incrementally back up to an additional disk.

OSCAR in a BOX is ideal for family physicians who wish to adopt OSCAR but does not have the technical support for maintaining the system. OSCAR in a BOX is plug and play and is virtually maintenance-free. The virtualization workflow will also be useful for existing bigger user groups reeling under the sluggish pace of OSCAR. Please let me know if anybody is interested in collaborating.

BTW, did you check out Drishti?

Originally published by Bell Eapen at nuchange.ca on August 20, 2019. If you have some feedback, reach out to the author on Twitter,  LinkedIn or  Github.

Categories
HIS

Drishti | An Open mHealth sense-plan-act framework based on FHIR!

Originally published by Bell Eapen at nuchange.ca on August 13, 2019. If you have some feedback, reach out to the author on TwitterLinkedIn  or  Github.

TL;DRHere is an open-source mHealth framework based on FHIR! and here is the paper and my presentation at ICSE!

Pervasive health monitoring is becoming less and less intrusive with better sensors, and more and more useful with machine learning and predictive analytics.

MHealth (mobile health) could play an important part in pervasive health monitoring. It is difficult for clinicians to efficiently use the data from disparate apps that do not communicate with each other. For example, if a clinician has to monitor a patient’s blood sugar, blood pressure and physical activity, the clinician may have to check data from multiple apps. Another challenge is the difficulty in communicating clinical requirements to app developers and it is difficult to test and approve the clinical validity of these apps. Besides, there are always privacy and security concerns with personal health information.

Open mHealth is a framework introduced to manage the problem of interoperability between apps. It is an open-source project. Open mHealth project provides interfaces for cloud services such as GoogleFit and Fitbit and converts the data into a common data format. BIT model deals with the communication problem between clinicians and developers during app development. Drishti incorporates Open mHealth framework into the BIT model using FHIR as the common data model.

The BIT model is based on the Sense-Plan-Act paradigm from robotics. The BIT model encourages conceptualizing mHealth apps as three distinct components: Profilers that sense data on various physiological parameters such as blood pressure, planners that create a clinical intervention plan and actors that deliver the plan to the users as alerts or messages on their mobile devices. Drishti adopts the BIT model as a design model with all components sharing a central data repository. Drishti makes sharing of information with the doctors easy, by integrating it into an EMR. The central data repository also makes big data applications possible.

The central data repository in Drishti uses FHIR schema for storage. FHIR is a schema for health data created by HL7 that defines ‘Resources’ that can be exchanged as json or xml using RESTful interfaces. Resources support 80% of common use cases and the rest can be supported using extensions. For example, age and gender are defined for a Patient resource, while skin type that is not commonly used is defined through an extension if required. Drishti uses the ‘Observation’ resource for storing data from profilers and the ‘CarePlan’ resource for the planner and actor components.

Open mHealth is the profiler in Drishti. All data from the various cloud services are converted to FHIR Observations and stored in the Drishti-Cog. The Drishti-Planner can take data stored in the cog and create a careplan and the actor can deliver it to the patient. Drishti uses OpenMRS EMR for managing access, both for clinicians and patients. We have developed an OpenMRS module for integration with Drishti. The javascript visualization library called hGraph provides a consolidated view of the data pulled from sensors to the clinician.

In the current implementation, the cog is a FHIR server based on the HAPI java library. Planner and actor components are just stubs that can be extended for several use cases. The planner is a python flask app and the viewer is a Vue App that can be used as a native mobile app. Both are templates that can be extended. The entire stack is available on GitHub along with pre-built Docker containers for quick prototyping.

Here is a typical use case. Depression is a common mental health problem, characterized by loss of interest in activities that you normally enjoy. Patients with depression are typically treated with anti-depressant drugs. The clinicians need to track the patient’s activity to assess progress along with medication compliance. The patient can use an activity tracker app and a medication tracker app, both sending data to the cog as FHIR observations. The clinicians can have a consolidated view in their EMR and create alerts or messages (plan) that can be delivered to the patient’s mobile device. The interventions can also be created by AI systems.

Drishti was presented at Software Engineering in Healthcare conference in Montreal and selected for FHIR devdays. Please cite Drishti as below:

Bell Raj Eapen, Norm Archer, Kamran Sartipi, and Yufei Yuan. 2019. Drishti: a sense-plan-act extension to open mHealth framework using FHIR. In Proceedings of the 1st International Workshop on Software Engineering for Healthcare (SEH ’19). IEEE Press, Piscataway, NJ, USA, 49-52. DOI: https://doi.org/10.1109/SEH.2019.00016

Categories
OpenSource Resources

Hephestus: Health data warehousing tool for public health and clinical research

Originally published by Bell Eapen at nuchange.ca on November 3, 2018. If you have some feedback, reach out to the author on TwitterLinkedIn or Github.

Health data warehousing is becoming an important requirement for deriving knowledge from the vast amount of health data that healthcare organizations collect. A data warehouse is vital for collaborative and predictive analytics. The first step in designing a data warehouse is to decide on a suitable data model. This is followed by the extract-transform-load (ETL) process that converts source data to the new data model amenable for analytics.

The OHDSI – OMOP Common Data Model is one such data model that allows for the systematic analysis of disparate observational databases and EMRs. The data from diverse systems needs to be extracted, transformed and loaded on to a CDM database. Once a database has been converted to the OMOP CDM, evidence can be generated using standardized analytics tools that are already available.

Each data source requires customized ETL tools for this conversion from the source data to CDM. The OHDSI ecosystem has made some tools available for helping the ETL process such as the White Rabbit and the Rabbit In a Hat. However, health data warehousing process is still challenging because of the variability of source databases in terms of structure and implementations.

Hephestus is an open-source python tool for this ETL process organized into modules to allow code reuse between various ETL tools for open-source EMR systems and data sources. Hephestus uses SqlAlchemy for database connection and automapping tables to classes and bonobo for managing ETL. The ultimate aim is to develop a tool that can translate the report from the OHDSI tools into an ETL script with minimal intervention. This is a good python starter project for eHealth geeks.

Anyone anywhere in the world can build their own environment that can store patient-level observational health data, convert their data to OHDSI’s open community data standards (including the OMOP Common Data Model), run open-source analytics using the OHDSI toolkit, and collaborate in OHDSI research studies that advance our shared mission toward reliable evidence generation. Join the journey! here

Disclaimer: Hephestus is just my experiment and is not a part of the official OHDSI toolset.

  • SSH URL
  • Clone URL
Categories
HIS

Serverless on FHIR: Management guidelines for the semi-technical clinician!

Originally published at nuchange.ca on February 12, 2018. If you have some feedback, reach out to the author on TwitterLinkedIn or Github.

Serverless is the new kid on the block with services such as AWS Lambda, Google Cloud Functions or Microsoft Azure Functions. Essentially it lets users deploy a function (Function As A Service or FaaS) on the cloud with very little effort. Requirements such as security, privacy, scaling, and availability are taken care of by the framework itself. As healthcare slowly yet steadily progress towards machine learning and AI, serverless is sure to make a significant impact on Health IT. Here I will explain serverless (and some related technologies) for the semi-technical clinicians and put forward some architectural best practices for using serverless in healthcare with FHIR as the data interchange format.

artificial intelligence
Serverless on FHIR

Let us say, your analyst creates a neural network model based on a few million patient records that can predict the risk for MI from BP, blood sugar, and exercise. Let us call this model r = f(bp, bs, e). The model is so good that you want to use it on a regular basis on your patients and better still, you want to share it with your colleagues. So you contact your IT team to make this happen.

This is what your IT guys currently do: First, they create a web application that can take bp, bs and e as inputs using a standard interface such as REST and return r. Next, they rent a virtual machine (VM) from a cloud provider (such as DigitalOcean). Then they convert this application into a container (docker) and deploy it in the VM. You now can use this as an application from your browser (chrome) or your EMR (such as OpenMRS or OSCAR) can directly access this function. You can share it with your colleagues and they can access it in their browsers and you are happy. The VM can support up to 3 users at a time.

In a couple of months, your algorithm becomes so popular that at any one time hundreds of users try to access it and your poor VM crashes most of the time or your users have to wait forever. So you call your IT guys again for a solution. They make 100 copies of your container, but your hospital is reluctant to give you the additional funding required.

Your smart resident notices that your application is being used only in the morning hours and in the night all the 100 containers are virtually sleeping. This is not a good use of the funding dollars. You contact your IT guys again, and they set up Kubernetes for orchestrating the containers according to usage. So, what is Serverless? Serverless is a framework that makes all these so easy that you may not even need your IT guys to do this. (Well, maybe that is an exaggeration)

My personal favourite serverless toolset (if you care) is Kubernetes + Knative + riff. I don’t try to explain what the last two are or how to use them. They are so new that they keep changing every day. In essence, your IT team can complete all the above tasks with few commands typed on the command line on the cloud provider of your choice. The application (function rather) can even scale to zero! (You don’t pay anything when nobody uses it and add more containers as users increase, scaling down in the night as in your case).

Best Practices

What are the best practices when you design such useful cloud-based ‘functions’ for healthcare that can be shared by multiple users and organizations? Well, here are my two cents!

First, you need a standard for data exchange. As JSON is the data format for most APIs, FHIR wins hands down here.

Next, APIs need a mechanism to expose their capabilities and properties to the world. For example, r = f(bp, bs, e) needs to tell everyone what it accepts (bp, bs, e) and what it returns (at the bare minimum). FHIR has a resource specifically for this that has been (not so creatively) named as an Endpoint. So, a function endpoint should return a FHIR Endpoint resource with information about itself if there is no payload.

What should the payload be? Payload should be a FHIR Bundle that has all the FHIR Resources that the function needs (bp, bs and e as FHIR Observations in your case). The bundle should also include a FHIR Subscription resource that points to the receiving system (maybe your EMR) for the response ( r ).

So, what next?

Take the phone and call your IT team. Tell them to take
Kubernetes + Knative + riff for a spin! I might do the same and if I do, I will share it here.

Categories
Research

eHealth against antimicrobial resistance

This article was first published on Brighter World. Read the original article.

A forward-looking McMaster donor is investing $7 million in a new research centre dedicated specifically to tackle the growing global threat of antimicrobial resistance.

David Braley, whose gifts to the university include a $50-million investment in McMaster teaching, learning and health-care research and delivery, has allocated $7 million from that 2007 gift towards the new David Braley Centre for Antibiotic Discovery.

The centre will operate from the Michael G. DeGroote Institute for Infectious Disease Research, whose labs and offices are located on campus in the Michael G. DeGroote Centre for Learning and Discovery.

Researchers associated with the new David Braley Centre for Antibiotic Discovery. Photo by Georgia Kirkos.

“This is a very timely investment,” says Paul O’Byrne, dean and vice- president, Faculty of Health Sciences. “This provides fresh resources to a team of researchers who are among the world’s leaders in their field. Creating this centre gives them the chance to do their best work at a time in history when it’s needed most.”

The funding comes from a portion of Braley’s 2007 gift that had been designated for emerging health-care research priorities.

The David Braley Centre for Antibiotic Discovery will be home to McMaster’s leading researchers in the field of antimicrobial resistance, or AMR. The new resources will allow the team to concentrate more specific effort on that problem.

“Antimicrobial resistance is a slow-moving catastrophe, but make no mistake: within the next 30 years, it will kill millions, strangle our health-care systems and significantly alter life as we know it unless we develop new ways to attack the problem,” says Gerry Wright, who heads both the David Braley Centre for Antibiotic Discovery and the Institute for Infectious Disease Research.  “The opportunity to open this centre is a hopeful sign, and we are grateful for Mr. Braley’s vision and his vote of confidence. This problem must be solved, and it can be solved.”

Dr. Gerry Wright standing at a podium in a hallway in front of a black curtain at the opening of the David Braley Centre for Antibiotic Discovery
Gerry Wright, director of the Institute for Infectious Disease Research and the new David Braley Centre for Antibiotic Discovery, addresses the crowd at the opening of the new research centre. Photo by Georgia Kirkos.

The waning effectiveness of traditional antibiotics gives urgency to the search for new forms of antibiotics and other ways to boost the effectiveness of existing drugs.

Widespread use of antibiotics in agriculture and medicine has accelerated resistance to penicillin and its related medicines, as bacteria evolve to meet the threat.

Infection control and treatment without antibiotics could cast the world back to the early 1900s, when infectious diseases routinely killed people, Wright says.

Today, at least 700,000 people around the world – including 2,000 in Canada ­­– die each year as a result of drug-resistant diseases. The global total is expected to rise to 10 million deaths per year by 2050 if no new solutions are found.

The medical costs associated with AMR are predicted to reach $100 trillion within that same time frame.

Close-up of a lab coat that reads "David Braley Centre for Antibiotic Discovery."
Photo by Georgia Kirkos.

This year, the United Nations published a report projecting that without immediate global action, AMR could force up to 24 million people into extreme poverty by the year 2030.

Categories
Research Resources

McMaster’s start-up incubator to receive $1.2 million from FedDev Ontario

This article was first published on Daily News. Read the original article.

The Government of Canada, through FedDev Ontario, is providing McMaster with $1.2 million to expand The Forge, a collaborative makerspace where entrepreneurs can access advanced equipment to design and build innovative new products.

 

Forge

The Honourable Filomena Tassi, Minister of Seniors and Member of Parliament for Hamilton West-Ancaster-Dundas, made the announcement today on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and minister responsible for FedDev Ontario.

“FedDev Ontario’s funding is providing invaluable support to the innovation community in Hamilton,” said Tassi. “The government of Canada is proud to support McMaster — one of Canada’s premier research-intensive universities — to expand The Forge’s makerspace and allow more companies to develop and bring new products to market.”

The funding will allow The Forge to expand its makerspace as it moves into a 10,000 square-foot facility shared with partner Innovation Factory. It will also purchase additional 3D printers and other fabricating equipment, and increase support to entrepreneurs through mentoring. As a result, the number of companies supported will almost double from 24 to up to 40 annually, with up to 75 new jobs created as a result.

“This strategic investment from the Government of Canada will strengthen the entrepreneurial capacity of our region by providing McMaster’s students and the wider Hamilton community access to the centralized expertise and infrastructure so essential for creating start-ups and business growth opportunities,” said Karen Mossman, Acting Vice-President of Research at McMaster and chair of the McMaster Innovation Park board of directors.

More than 105 tech companies have graduated from The Forge since its founding in 2014, with more than 300 employees hired and $20 million of private and public investment raised.

The Forge’s expansion further enhances McMaster’s entrepreneurial ecosystem and reputation as a leader in developing innovative manufacturing assets, in particular within the McMaster Innovation Park, which is also home to the McMaster Automotive Research Centre (MARC) and the Centre for Biomedical Engineering and Advanced Manufacturing (BEAM).

This article was first published on Daily News. Read the original article.